Otonomy Initiates Phase 1 Clinical Trial for Tinnitus Product Candidate, OTO-311
16 nov. 2015 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...